Levothyroxine Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 42023-203

8 FDA label images from Endo Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 42023-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100vial (Pa506107 403208)

100vial (Pa506107 403208)
Label for Levothyroxine Sodium Injection, powder, lyophilized, for solution with a strength of 100 mcg per vial. Intended for intravenous use as a single dose vial, with instructions to discard unused portion. Label includes storage instructions, manufacturer ENDO USA, Inc., and barcode.*
FDA Label Image

Carton (Pa506107 621524)

Carton (Pa506107 621524)
Label for Levothyroxine Sodium injection, powder, lyophilized, for solution. The vial strength shown is 100 mcg per vial. The product is intended for intravenous use and is a single dose vial. The label includes instructions to discard any unused portion. The label is from ENDO USA, Inc.*
FDA Label Image

200 (Pa506247 403206)

200 (Pa506247 403206)
Label for Levothyroxine Sodium Injection, 200 mcg per vial, lyophilized powder for intravenous use. The single-dose vial contains 200 mcg in a 5 mL volume. The label includes preparation and storage instructions, barcodes, and identifies ENDO USA, Inc. as the labeler, located in Chesterbrook, PA.*
FDA Label Image

200 (Pa506247 621526)

200 (Pa506247 621526)
Levothyroxine Sodium injection label showing a 200 mcg per vial strength for intravenous use. The label indicates a single dose vial with instructions to discard any unused portion. The product is prescription only.*
FDA Label Image

500 (Pa506248 403207)

500 (Pa506248 403207)
Label for Levothyroxine Sodium Injection, 500 mcg per vial, lyophilized powder for intravenous use. The label indicates it is a single-dose vial, sterile, and for Rx use only. It includes directions for reconstitution and storage, with the labeler identified as Endo Pharmaceuticals, Chesterfield, MO 63017.*
FDA Label Image

500c (Pa506248 621525)

500c (Pa506248 621525)
Label for Levothyroxine Sodium injection, powder, lyophilized, for solution, 500 mcg per vial. The label indicates it is for intravenous use, single dose vial, and Rx only. The NDC code shown is 42023-203-01, and the labeler is ENDO USA, Inc.*
FDA Label Image
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of levothyroxine sodium anhydrous, showing the arrangement of iodine atoms, hydroxyl groups, amino group, and carboxylate sodium salt characteristic of this compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.